About Us | Contact Us |        
LOGIN OR REGISTER
Course Library

Recognition, Diagnosis, and Management of Children and Adolescents with Hereditary Angioedema

Allergy/ Immunology
Curriculum:
HAE Diagnosis and Management
Credits:
1 AMA PRA Category 1 Credit(s) ™
Launch Date:
February 04, 2014
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

This activity has been designed to meet the educational needs of pediatricians, general and family physicians, and other healthcare providers involved in the management of pediatric patients with hereditary angioedema (HAE).

Relevant Terms:

Allergy, Angioedema, Gastroenterology, Hereditary Angioedema, Pediatrics, Primary Care

Aleena Banerji, MD

Aleena Banerji, MD
Assistant Professor of Medicine
Harvard Medical School
Assistant Training Program Director
Massachusetts General Hospital
Boston, Massachusetts

Aleena Banerji, MD, is Assistant Professor of the Department of Medicine at Harvard Medical School in Boston, Massachusetts. She is also Assistant Training Program Director and Director of the Drug Allergy Center at Massachusetts General Hospital in Boston.
 
Dr. Banerji received her medical degree from Northwestern University Medical School in Chicago, Illinois and her internal medicine training at the University Hospitals of Cleveland/Case Western Reserve University in Cleveland, Ohio. She is board certified in internal medicine and a member of the American Board of Internal Medicine and American Board of Allergy & Immunology. After completing her residency at Northwestern University Medical School, she completed a fellowship in allergy/immunology at Massachusetts General Hospital.
 
Dr. Banerji is a member of the American College of Allergy, Asthma & Immunology, the American Academy of Allergy, Asthma & Immunology, and the Massachusetts Asthma and Allergy Society.
 
Dr. Banerji's major clinical interests include drug allergy, asthma, immunodeficiency, rhinosinusitis, cough, anaphylaxis, angioedema, eosinophilic disorders, food sensitivity, nasal polyposis, dermatitis, urticaria, and immunology.

Michael S. Blaiss, MD

Michael S. Blaiss, MD
Clinical Professor
Department of Pediatrics and Medicine
University of Tennessee Health Sciences Center
Memphis, Tennessee

Michael S. Blaiss, MD, is a pediatric and adult allergist widely recognized as an international thought leader in the field of allergy and asthma management. He is a Clinical Professor of Pediatrics and Medicine at the University of Tennessee Health Sciences Center and has a private practice at Allergy and Asthma Care in Memphis, Tennessee.

Dr. Blaiss' clinical focus is on allergies and allergic disorders, especially dealing with quality of life, outcomes, and economic issues. He has been named to the Best Doctors in America list from 1999-2010. In 2009, he was named by USA Today as one of the most influential physicians in asthma care.
 
Dr. Blaiss has published more than 100 scientific articles and presented at more than 400 meetings and seminars throughout the world on such topics as allergic rhinitis, asthma, socioeconomic subjects in allergy and asthma, and issues in compliance and adherence.

He has written for several peer-reviewed journals, including Journal of Pediatrics, Journal of Allergy and Clinical Immunology, Journal of the American Medical Association, as well as several allergy textbooks. He has co-edited Atlas of Allergic Diseases. In addition, he has been a member of the editorial boards for the Annals of Allergy, Asthma & Immunology, World Allergy Organization Journal, Journal of Asthma, Allergy and Asthma Proceedings, and American Journal of Rhinology and Allergy. Dr. Blaiss is presently Contributing Editor for the Asthma Resource Center for Epocrates.com.

Dr. Blaiss is on the Board of Directors of the World Allergy Organization. He is a past president of the American College of Allergy, Asthma & Immunology (ACAAI) and has served on the Board of Directors for the American Board of Allergy & Immunology. He has been President of the Louisiana State Allergy Society and the Tennessee Society of Allergy, Asthma & Immunology. Dr. Blaiss is a Fellow of the American Academy of Allergy, Asthma & Immunology and the ACAAI.

William R. Lumry, MD

William R. Lumry, MD
Clinical Professor
Department of Internal Medicine/Allergy
University of Texas
Southwestern Medical School
Private Practice
Dallas, Texas

William R. Lumry, MD, is a board-certified internist and allergist. He is in private practice in Dallas, Texas treating adults and children with allergic diseases and asthma. He is a Clinical Professor of Internal Medicine at the University of Texas Southwestern Medical School and teaches at Parkland Memorial and Presbyterian Hospitals in Dallas.
 
Dr. Lumry received his medical degree from the University of Texas Medical Branch at Galveston, Texas, completed his internal medicine training at Washington University in St. Louis, Missouri, and received his clinical and research fellowship in allergy and immunology from Scripps Clinic in La Jolla, California.
 
Dr. Lumry is a Fellow of the American College of Physicians, American Academy of Allergy, Asthma & Immunology, and American College of Allergy, Asthma & Immunology.
 
He is the medical director of Allergy and Asthma Research Association Research Center and participates actively in clinical research projects involving new treatments for asthma, allergic diseases, and HAE. He has lectured to local, national, and international conferences and published many articles and abstracts in prominent medical journals on these subjects.
1. Recognize the most common symptoms of HAE to minimize delays in diagnosis in children and adolescents
2. Describe appropriate therapies for both on-demand and prophylactic treatment of children and adolescents with HAE
3. Explain strategies for observation, education, referral, and follow-up of patients receiving on-demand or prophylactic therapy for HAE

Activity Length

The estimated time required to complete this activity is 1.0 hour.

Accreditation Statement

Integrity Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Integrity Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest (COI)
 
Integrity Continuing Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
 
Sean Gregory, PhD
Has no real or apparent conflicts of interest to report.

Aleena Banerji, MD
Consultant: Dyax, Shire
Research: Dyax, Shire, ViroPharma
 
Michael S. Blaiss, MD
Has no real or apparent conflicts of interest to report.
 
William R. Lumry, MD
Consultant: CSL Behring, Dyax, Genentech, Meda, Novartis, Shire HGT, ViroPharma
Speaker: Genentech, Meda, Novartis, Shire HGT, ViroPharma
Research: ADMA, CSL Behring, Dyax, Forest Laboratories, Genentech, Green Cross, Kedron, Meda, Merck, Shinogi, Shire HGT, Teva, ViroPharma

Disclosure of Unlabeled Use
 
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education and ViroPharma do not recommend the use of any agent outside of the labeled indications.
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education and ViroPharma. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Directions to Learners
 

There are no fees for participating and receiving CME credit for this activity. Participants must:
 
  • Read the learning objectives and faculty disclosures 
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest and evaluation form
A statement of credit will be issued upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.
 
Media
 
Internet

For questions about the accreditation of this program, please contact Integrity Continuing Education, Inc. at (888) 255-1009 or information@integrityce.com.

 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above		 Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

 

Schedule an event with a Standardized Patient
×